Title:
GUANABENZ-CONTAINING COMPOUND FOR THE TREATMENT OF PRIMARY CUTANEOUS AMYLOIDOSIS
Document Type and Number:
WIPO Patent Application WO/2012/083397
Kind Code:
A8
Abstract:
This invention refers to the pharmaceutical composition with guanabenz as active ingredient and is indicated for the treatment of primary cutaneous amyloidosis. The composition of this invention can be supplied as cream, gel, jelly cream, ointment, lotion or any other dosage form intended for topical use. The effect of guanabenz on the anomalous proteins that cause primary cutaneous amyloidosis, according to this invention, is not related to the action of this drug as alpha-2 adrenergic agonist, as is the case for the other indications of this substance according to the state of the art.
Inventors:
SANTOS OMAR LUPI DA ROSA (BR)
DA CRUZ LUIS EDUARDO (BR)
DA CRUZ LUIS EDUARDO (BR)
Application Number:
PCT/BR2011/000480
Publication Date:
January 03, 2013
Filing Date:
December 20, 2011
Export Citation:
Assignee:
SILVESTRE LABS QUIMICA E FARMACEUTICA LTDA (BR)
SANTOS OMAR LUPI DA ROSA (BR)
DA CRUZ LUIS EDUARDO (BR)
SANTOS OMAR LUPI DA ROSA (BR)
DA CRUZ LUIS EDUARDO (BR)
International Classes:
A61K31/155; A61P17/00
Attorney, Agent or Firm:
DANNEMANN, SIEMSEN, BIGLER & iPANEMA MOREIRA (Rua Marquês de Olinda 70 - Botafogo, -040- Rio de Janeiro - RJ, BR)
Download PDF: